Structural Changes of Subcutaneous Tissue by Ultrasonographies in Patients After Treatment With PnKCelulitis® Program
Launched by PROTEIN SUPPLIES SL · May 25, 2018
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Females older than 18, with normal weight ranges in addition to the presence of cutaneous non-infectious cellulite (edematous-fibrosclerotic panniculopathy), were recruited for the study and to undergo treatment with the multidisciplinary programme.
All patients were treated with the specific multidisciplinary programme for cellulite (PnKCelulitis®). This programme consists of three phases or processes: the restructuring, drainage and toning processes, each of which combines diet, physical exercise and the application of an anti-cellulite cream that combines active lipolytic and vasodilato...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females older than 18 years
- • Normal weight ranges
- • Presence of cutaneous non-infectious cellulite (edematous-fibrosclerotic panniculopathy)
- • Women who are going to begin treatment with the multidisciplinary programme
- Exclusion Criteria:
- • Pregnant or lactating females
- • Contraindications of a ketogenic diet
About Protein Supplies Sl
Protein Supplies SL is a leading clinical trial sponsor dedicated to advancing the field of nutritional science through innovative research and development. Specializing in protein-based products, the company focuses on conducting rigorous clinical trials to evaluate the efficacy and safety of its offerings. With a commitment to quality and scientific integrity, Protein Supplies SL collaborates with healthcare professionals and research institutions to contribute valuable insights into dietary supplementation and its impact on health outcomes. Their mission is to enhance nutritional strategies and improve overall well-being through evidence-based solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Esther Roe, Ph
Principal Investigator
Hosptial de al Santa Creu i Sant pau
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials